Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 459)
Posted On: 12/22/2021 10:55:01 AM
Post# of 36573
Posted By: rjs9787
Re: Beasley #34114
This sounds paste tense, although it could be an error.

“In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.”

///
“Mr. Corrao served as the Chief Financial Officer for Generex Biotechnology Corporation (OTCQB:GNBT), a drug development company, and its subsidiaries.”

https://www.google.com/amp/s/www.marketscreen...-37390119/

He does sometimes hold different CFO roles simultaneously, as the head of the CFO Group. I wonder if his new client is aware that at Generex he’s CFO of a company delinquent in SEC financial reporting?













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site